← SynDRA
TC-S-7006
SynDRA canonical compound SYN0053348 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | MAP3K8 |
|---|
| Mechanism of action | MAP kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- MAP3K8 INHIBITOR
- MEK inhibitor
Cross-references
Synonyms
- Tpl2 Kinase Inhibitor
- RefChem:190532
- DTXCID90380388
- Tpl2 Kinase Inhibitor 1
- K00599a
- MFCD12405303
- Tpl2-IN-2p
- C21H14ClFN6
- GTPL6051
- orb1706520
- SCHEMBL2369872
- SCHEMBL29944932
- SCHEMBL30264449
- GLXC-06063
- HMS3229O22
- HMS3751I09
- EX-A9516
- BDBM50173832
- AKOS015917405
- CCG-206888
- SDCCGSBI-0086790.P003
- NCGC00387471-01
- DA-58368
- HY-12358
- MS-26924
- CS-0011091
- G13796
- T17145
- Tpl2 kinase inhibitor
- 4-[(3-Chloro-4-fluorophenyl)amino]-6-[(3-pyridinylmethyl)amino]-1,7-naphthyridine-3-carbonitrile
Look up TC-S-7006 in the interactive SynDRA portal →